Gossamer Bio, Inc. (GOSS) Revenue History
Gossamer Bio, Inc. (GOSS) annual revenue history. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2019-12-31 | N/A |
| 2020-12-31 | N/A |
| 2021-12-31 | N/A |
| 2022-12-31 | N/A |
| 2023-12-31 | N/A |
| 2024-12-31 | $114.70M |
| 2025-12-31 | $48.47M |
How GOSS compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| ENTA | Enanta Pharmaceuticals Inc. | $65.32M |
| NKTR | Nektar Therapeutics | $55.23M |
| OCUL | Ocular Therapeutix Inc. | $51.95M |
| AQST | Aquestive Therapeutics Inc. | $44.55M |
| VYGR | Voyager Therapeutics Inc. | $40.37M |
These are five companies in the same sector as GOSS with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Gossamer Bio, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("GOSS", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | GOSS | $0.18 | -0.17% | 8.09M |
| 3 | ||||
| 4 | ||||
| 5 |